Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 23, Issue 2

2016 April - 23 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
25 Citations
1,709 Views
10 Pages

1 April 2016

Background: In 2009, the Program in Evidence-based Care (pebc) of Cancer Care Ontario published a guideline on the follow-up of cervical cancer. In 2014, the pebc undertook an update of the systematic review and clinical practice guideline for women...

  • Short Communication
  • Open Access
4 Citations
833 Views
6 Pages

A First Look at Relative Survival by Stage for Colorectal and Lung Cancers in Canada

  • J. Chadder,
  • R. Dewar,
  • L. Shack,
  • D. Nishri,
  • J. Niu and
  • G. Lockwood

1 April 2016

Monitoring and reporting on cancer survival provides a mechanism for understanding the effectiveness of Canada’s cancer care system. Although 5-year relative survival for colorectal cancer and lung cancer has been previously reported, only recently h...

  • Meeting Report
  • Open Access
3 Citations
896 Views
6 Pages

Report on a Delphi Process and Workshop to Improve Accrual to Cancer Clinical Trials

  • J.A.H. Bell,
  • L.G. Balneaves,
  • M.T. Kelly and
  • H. Richardson

1 April 2016

Cancer clinical trials (ccts) are essential for furthering knowledge and developing effective interventions to improve the lives of people living with cancer in Canada. Randomized controlled trials are particularly important for developing evidence-b...

  • Article
  • Open Access
14 Citations
1,409 Views
6 Pages

Research Output and the Public Health Burden of Cancer: Is There Any Relationship?

  • F.M. Patafio,
  • S.C. Brooks,
  • X. Wei,
  • Y. Peng,
  • J. Biagi and
  • C.M. Booth

1 April 2016

Purpose: The relative distribution of research output across cancer sites is not well described. Here, we evaluate whether the volume of published research is proportional to the public health burden of individual cancers. We also explore whether res...

  • Article
  • Open Access
22 Citations
1,201 Views
10 Pages

1 April 2016

Background: Cancer quality indicators have previously been described for a single tumour site or a single treatment modality, or according to distinct data sources. Our objective was to identify cancer quality indicators across all treatment modaliti...

  • Article
  • Open Access
16 Citations
1,423 Views
5 Pages

1 April 2016

Background: Outcomes in metastatic breast cancer (MBC) positive for HER2 (human epidermal growth factor receptor 2) are generally unfavourable. Trastuzumab has revolutionized the prognosis of HER2-positive mbc. Some HER2-positive mbc patients go into...

  • Article
  • Open Access
34 Citations
3,861 Views
13 Pages

Canadian Recommendations for the Management of Breakthrough Cancer Pain

  • P. Daeninck,
  • B. Gagnon,
  • R. Gallagher,
  • J.D. Henderson,
  • Y. Shir,
  • C. Zimmermann and
  • B. Lapointe

1 April 2016

Breakthrough cancer pain (BTCP) represents an important element in the spectrum of cancer pain management. Because most BTCP episodes peak in intensity within a few minutes, speed of medication onset is crucial for proper control. In Canada, several...

  • Article
  • Open Access
26 Citations
1,327 Views
7 Pages

Formal Evaluation of PYNK: Breast Cancer Program for Young Women—The Patient Perspective

  • L. Cohen,
  • J. Hamer,
  • C. Helwig,
  • K. Fergus,
  • A. Kiss,
  • R. Mandel,
  • B. Dawson,
  • A. Landsberg,
  • K. Shein and
  • E. Warner
  • + 1 author

1 April 2016

Purpose: The aim of the present study was to assess patient satisfaction with PYNK: Breast Cancer Program for Young Women so as to determine how the program might be improved and to provide feedback to donors. Methods: All PYNK patients who had conse...

  • Article
  • Open Access
17 Citations
1,474 Views
7 Pages

1 April 2016

Objectives: The objectives of the present study were to estimate the overall and specific medical care costs associated with cervical cancer in the first 5 years after diagnosis in Ontario. Methods: Incident cases of invasive cervical cancer during 2...

  • Article
  • Open Access
35 Citations
1,548 Views
7 Pages

1 April 2016

Background: Recent studies have suggested an effect of metformin on mortality for patients with both diabetes and colorectal cancer (CRC). However, the literature is contradictory, with both positive and negative effects being identified. We set out...

  • Article
  • Open Access
5 Citations
1,142 Views
8 Pages

Hematogones: A Sensitive Prognostic Factor for Chinese Adult Patients with Acute Myeloid Leukemia

  • L. Li,
  • R. Fu,
  • T. Zhang,
  • X. Xie,
  • J. Liu,
  • J. Tao,
  • J. Song,
  • H. Liu,
  • W. Zhang and
  • Z. Shao
  • + 1 author

1 April 2016

Background: Hematogones (HGS) are normal B-lymphocyte precursors that increase in some hematologic diseases. Many studies indicate that HGS might be a favourable prognostic factor. We thus considered it important to determine whether HGS are also a p...

  • Article
  • Open Access
15 Citations
1,018 Views
7 Pages

Involved-Field Irradiation in Definitive Chemoradiotherapy for T4 Squamous Cell Carcinoma of the Esophagus

  • M. Li,
  • F. Zhao,
  • X. Zhang,
  • F. Shi,
  • H. Zhu,
  • A. Han,
  • Y. Zhang,
  • L. Kong and
  • J. Yu

1 April 2016

Objectives: Definitive concurrent chemoradiotherapy (CCRT) is currently a therapeutic option for locally advanced esophageal cancer. However, clinical practice differs with respect to the target volume for irradiation. The purpose of the present stud...

  • Article
  • Open Access
3 Citations
954 Views
6 Pages

Collaborative Case Conferences in Rectal Cancer: Case Series in a Tertiary Care Centre

  • C. Eskicioglu,
  • S. Forbes,
  • S. Tsai,
  • V. Francescutti,
  • A. Coates,
  • V. Grubac,
  • R. Sonnadara and
  • M. Simunovic

1 April 2016

Background: In many hospitals, resource barriers preclude the use of preoperative multidisciplinary cancer conferences (MCCS) for consecutive patients with cancer. Collaborative cancer conferences (CCCS) are modified MCCS that might overcome such bar...

  • Short Communication
  • Open Access
4 Citations
994 Views
6 Pages

1 April 2016

Background: More than 30 exposures in the workplace are proven carcinogens. In the present study, we aimed to estimate the burden of occupational cancer in Quebec so as to increase awareness among stakeholders and to prioritize research activities. M...

  • Case Report
  • Open Access
11 Citations
932 Views
4 Pages

1 April 2016

Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumour of the skin. Remission rates are high with chemotherapy in patients with metastasis, but without any improvement in overall survival. We present the case of a 90-year-old woman...

  • Case Report
  • Open Access
4 Citations
710 Views
4 Pages

Synchronous Metastatic Skull Base Chordoma to the Breast: Case Report and Literature Review

  • S.I. Shakir,
  • M. Pelmus,
  • A. Florea,
  • J.F. Boileau,
  • M.C. Guiot,
  • S. Di Maio and
  • T.M. Muanza

1 April 2016

Clinical Scenario: During routine staging work-up for a left breast mass, a 68-year-old woman complained of dysphagia and dysphonia. During further investigations, a left-sided lesion at the foramen magnum was observed on brain imaging. Both lesions...

  • Letter
  • Open Access
1 Citations
661 Views
2 Pages

Second-Line Treatment of Non-Small-Cell Lung Cancer with Wild-Type EGFR Status. What Is the Best Approach?

  • Ibrahim Elghissassi,
  • Saber Boutayeb,
  • Hanane Inrhaoun,
  • Hind Mrabti and
  • Hassan Errihani

1 April 2016

We read with great interest the article of Ma and colleagues titled “An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world prac...

  • Article
  • Open Access
33 Citations
1,190 Views
9 Pages

MicroRNA Expression Profiling of Sputum for the Detection of Early and Locally Advanced Non-Small-Cell Lung Cancer: A Prospective Case–Control Study

  • R. Razzak,
  • E.L.R. Bédard,
  • J.O. Kim,
  • S. Gazala,
  • L. Guo,
  • S. Ghosh,
  • A. Joy,
  • T. Nijjar,
  • E. Wong and
  • W.H. Roa

1 April 2016

Background: Non-small-cell lung cancer (NSCLC) is associated with very poor overall survival because 70% of patients present with locally advanced or metastatic disease at the time of diagnosis. MicroRNAS (miRNAS) are a class of short, noncoding RNA...

  • Article
  • Open Access
8 Citations
977 Views
7 Pages

1 April 2016

Background: Although APPL1 is overexpressed in many cancers, its status in gastric cancer (GC) is not known. In the present study, we used relevant pathologic and clinical data to investigate APPL1 expression in patients with GC. Methods: In 47 GC an...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729